SCHEMBL12070694

SCHEMBL12070694

COc1cc2cc(-c3cccc(-c4ccccc4)c3)nc(CN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)c2cc1OC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CTSL P07711 1/20 0.40
▸ ACACB O00763 4/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ ACACA Q13085 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MAPKAPK2 P49137 1/20 0.37
▸ RAC1 P63000 2/20 0.36
▸ PTGDR Q13258 1/20 0.36
▸ MTNR1A P48039 1/20 0.36
▸ MTNR1B P49286 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12072754 0.93 KDM4E (0.41) KDM4EALDH1A1MAPTCTSLACACB
SCHEMBL14930631 0.92 KDM4E (0.39) KDM4EALDH1A1MAPTCTSLACACB
SCHEMBL12071571 0.90 KDM4E (0.41) KDM4EALDH1A1MAPTCTSLACACB
SCHEMBL14927108 0.89 MAPKAPK2 (0.38) ACACBACACACYP1A2CYP3A4CYP2C9
SCHEMBL14927100 0.82 DHODH (0.35) ACACBDHODHACACACYP1A2CYP3A4
SCHEMBL14927104 0.81 MAPKAPK2 (0.35) ACACBACACACYP1A2CYP3A4CYP2C9
SCHEMBL12070768 0.80 KDM4E (0.52) KDM4EALDH1A1MAPTDHODHACACA
SCHEMBL14927113 0.79 MAPKAPK2 (0.35) ACACBACACACYP1A2CYP3A4CYP2C9
SCHEMBL9986006 0.77 KDM4E (0.56) KDM4EALDH1A1MAPTDHODHACACA
SCHEMBL12070767 0.76 KDM4E (0.49) KDM4EALDH1A1MAPTDHODHACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed
WO-2011159926-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-22 — — WO disclosed
WO-2011156626-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2011-12-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 KDM4E 2572/4885ALDH1A1 3341/4885MAPT 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback